Plumbing the link between anti-CASPR2 antibodies and autism; and more

Here is a roundup of autism-related news and research spotted around the web for the week of 1 December.

By Jill Adams
2 December 2025 | 1 min read

Deep dive: Maternal antibodies that target a protein called CASPR2 are linked to autism, according to previous research. Two new papers offer deeper insight into that connection. One found that in-utero exposure to anti-CASPR2 antibodies leads to a decrease in both parvalbumin-positive interneurons and inhibitory synapses in the hippocampus in male mice. The other investigated novel variants of anti-CASPR2 antibodies—ones that recognize different epitopes of the protein, which resulted in a range of behavioral phenotypes in male mice. The Transmitter has covered previous work on anti-CASPR2 antibodies.

Protein paucity: Mice exposed to anti-CASPR2 antibodies in utero (right panels) show decreased expression of parvalbumin (green) compared with control mice (left panels).

Sign up for our weekly newsletter.

Catch up on what you missed from our recent coverage, and get breaking news alerts.

privacy consent banner

Privacy Preference

We use cookies to provide you with the best online experience. By clicking “Accept All,” you help us understand how our site is used and enhance its performance. You can change your choice at any time. To learn more, please visit our Privacy Policy.